0.39
+0.001(+0.26%)
Currency In USD
| Previous Close | 0.39 |
| Open | 0.4 |
| Day High | 0.4 |
| Day Low | 0.39 |
| 52-Week High | 1.8 |
| 52-Week Low | 0.31 |
| Volume | 171,524 |
| Average Volume | 1.08M |
| Market Cap | 12.81M |
| PE | -0.46 |
| EPS | -0.86 |
| Moving Average 50 Days | 0.71 |
| Moving Average 200 Days | 1.06 |
| Change | 0 |
If you invested $1000 in Femasys Inc. (FEMY) since IPO date, it would be worth $32.76 as of September 15, 2025 at a share price of $0.393. Whereas If you bought $1000 worth of Femasys Inc. (FEMY) shares 3 years ago, it would be worth $228.55 as of September 15, 2025 at a share price of $0.393.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
GlobeNewswire Inc.
Sep 11, 2025 1:00 PM GMT
-- Following the Setup Kit, the Insemination Kit completes the sperm preparation portion of FemSperm enabling gynecology call point activation to drive revenue growth --ATLANTA, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a lead
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
GlobeNewswire Inc.
Sep 08, 2025 1:00 PM GMT
Expands international footprint with entry into Asia-Pacific, building on recent CE Mark and UK approvalsATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical perma
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
GlobeNewswire Inc.
Sep 02, 2025 1:00 PM GMT
--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health-- ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovato